Brunswick Corporation filings document the public-company reporting of a marine recreation manufacturer with common stock and listed senior notes. Form 8-K reports include quarterly and annual earnings releases, non-GAAP financial measures used in management reporting, dividend-related and other material events, and debt-capital actions involving senior notes.
Proxy materials cover governance, shareholder voting matters, capital-structure disclosure, and operating and financial results. Other filings in the record document note tender offers, redemptions, and exchange notifications, including the removal from listing and registration of a senior note class.
Brunswick Corporation executive Christopher F. Dekker, EVP, General Counsel & Secretary, reported two transactions in Brunswick common stock. On February 6, 2026, he sold 4,981 shares at a weighted average price of $87.38 per share, in trades ranging from $86.63 to $88.29, leaving 39,740 directly held shares.
On February 9, 2026, he made a gift of 300 shares at $0, after which his direct holdings were 39,440 shares. Footnotes state his beneficial holdings include 355 shares from dividend reinvestment through December 2025 and an estimated 3,569 shares held indirectly through a savings plan trustee as of February 9, 2026.
A shareholder of Brunswick Corporation filed a notice of proposed Rule 144 sale covering 4,981 shares of common stock, with an aggregate market value of $435,248.75. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of February 6, 2026.
The securities being sold were originally acquired from the issuer as performance shares and restricted stock on several dates between 2019 and 2024. The notice also includes a representation that the selling shareholder is not aware of undisclosed material adverse information about Brunswick’s current or prospective operations.
Brunswick Corporation’s chief executive officer, David M. Foulkes, reported an open-market sale of company stock. On February 5, 2026, he sold 38,266 shares of Brunswick common stock at a weighted average price of $86.56, with individual trade prices ranging from $85.55 to $87.64.
After this transaction, he beneficially owns 271,169 Brunswick shares directly and an additional estimated 7,121 shares indirectly through a savings plan trustee. His beneficial holdings include 4,647 shares that were acquired through dividend reinvestment through December 2025.
A shareholder of company BC has filed a Form 144 indicating an intent to sell 38,266 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/05/2026 on the NYSE. The filing lists an aggregate market value for these shares of $3,312,370.01 and notes that there are 65,036,590 shares of the same class outstanding.
The shares to be sold were acquired as performance shares from the issuer on 02/16/2023, in a non-cash transaction described as “Not Applicable” for the nature of payment. The signer represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Brunswick Corporation director J. Steven Whisler reported receiving 961 shares of Brunswick common stock on January 30, 2026, at a price of $80.22 per share. These are deferred shares credited to his director deferred account and will be paid out in predetermined installments after he leaves the board.
Following this transaction, Whisler beneficially owns 96,948 common shares directly, which include 517 shares from dividend reinvestments in December 2025, and an additional 1,000 shares indirectly held by a family trust.
Brunswick Corporation director David V. Singer reported acquiring 981 shares of the company’s common stock on January 30, 2026 at $80.22 per share. Following this transaction, he directly holds 35,203 shares, including 412 deferred shares that will be paid out after he leaves the board and 150 shares received through dividend reinvestment in December 2025.
In addition to his direct holdings, 19,789 shares are held indirectly through the Barbara B Singer 2014 Irrevocable Trust, reflecting additional beneficial ownership reported in this filing.
Brunswick Corporation director Joseph W. McClanathan reported an acquisition of company stock. On 01/30/2026, he acquired 934 shares of Brunswick common stock at $80.22 per share. After this transaction, he beneficially owned 26,898 shares held directly.
Footnotes explain that 412 of these shares are deferred into a director deferred account, to be distributed in installments after he leaves the board. His beneficial holdings also include 122 shares received through dividend reinvestment in December 2025.
Brunswick Corporation director Lauren Patricia Flaherty reported acquiring 522 shares of Brunswick common stock on January 30, 2026 at $80.22 per share. These are deferred shares credited to the director’s deferred account and are scheduled to be paid out in predetermined installments after she leaves the board.
Following this transaction, Flaherty beneficially owns 16,959 Brunswick shares, held directly. This total includes 94 shares that were added through dividend reinvestments in December 2025.
Brunswick Corporation director Roger Wood reported an acquisition of company stock through a Form 4 filing. On January 30, 2026, he acquired 545 shares of Brunswick common stock at a price of $80.22 per share, recorded as an acquisition of non-derivative securities.
Following this transaction, Wood beneficially owned 66,698 shares of Brunswick common stock, held directly. The filing notes that his beneficial holdings include 380 shares that were added earlier through dividend reinvestment in December 2025, and that the new shares are deferred and will be distributed after he ceases serving as a director.
Brunswick Corporation director David C. Everitt reported an acquisition of 697 shares of Brunswick common stock on January 30, 2026, at $80.22 per share. The shares were credited as deferred stock into his director deferred account and will be paid out in set installments after he leaves the board.
Following this transaction, Everitt directly beneficially owned 38,020 Brunswick shares, which include 215 shares acquired through dividend reinvestments in December 2025.